Launch of Phase 2 of the application evaluation in Amman, Jordan
Share
Share on Facebook
Share on Telegram
Share on LinkedIn
Share on Twitter
Copy link
Page url is copied
Phase 2 of the evaluation of the application began in February in Amman. This essential step consists in testing the performance and the functioning of the expert system in order to calibrate the image processing by the artificial intelligence present in the application.
The MSF Foundation is innovating by adapting a tool to help healthcare workers manage diabetic ketoacidosis, a severe acute complication in children with diabetes.
In 2025, the Antibiogo application is seeing wide deployment, extending beyond MSF field operations. After being adopted by all MSF laboratories in 2024, the tool has also been integrated...
